In December 2019 the Snowdome Chair, Roger Greenman AM, announced to the Board that 2020 would be his 6th and final year at the helm of Snowdome, before retiring.
On behalf of Australian Blood Cancer patients, the Board would like to thank Roger for his dedicated service to our mission, which has seen Snowdome’s impact increase substantially, year on year under his guidance. A highlight being the $5.3m contribution Snowdome made to Blood Cancer research in the 2020 financial year, making Snowdome one of the largest financial contributors in the search for cures for Blood Cancer in Australia.
Roger shared ‘It has been an honour and a privilege to be Chair of Snowdome and to know that the Snowdome Foundation has made, and will continue to make a huge contribution to help Australian blood cancer patients live longer better lives. I look forward to continuing my involvement with Snowdome and know that under the Chair of John Salvaris, Snowdome is assured of a strong and vibrant future.’
Snowdome have appointed John Salvaris as its new Chair. John, a Partner at KPMG, has been a member of the Snowdome Board for the last 3 years as well as being Chair of the ground-breaking Christine and Bruce Wilson Centre for Lymphoma Genomics. The Board were unanimous in support of John and are looking forward to building further on our impact under his leadership.